GENEVA, Oct. 1 -- ELI LILLY AND COMPANY filed a patent application (US2026/018601) for “SUBSTITUTED FUSED PYRROLO[3,4-B]PYRIDINE COMPOUNDS AS AMYLIN RECEPTOR AGONISTS AND THEIR USE AS THERAPIES”. With publication no. WO/2026/193092, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/437
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....